Clinical Trials Using Tazarotene

Clinical trials are research studies that involve people. The clinical trials on this list are studying Tazarotene. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Topical Tazarotene 0.1% Gel for the Prevention of Regorafenib-Induced Hand-Foot-Skin Reactions

    This phase II trial studies how well topical tazarotene gel 0.1% works in preventing regorafenib-induced hand-foot-skin reactions in patients undergoing regorafenib treatment for solid tumors. Topical tazarotene is a drug used on the skin to treat several skin conditions and may to help reduce regorafenib-induced hand-food-skin reactions.
    Location: Dana-Farber Cancer Institute, Boston, Massachusetts